Arobella Medical CEO issued US Patent for Ultrasound Technology

     Arobella Medical LLC (Minneapolis, Minn) announced that its Co-founder, President and CEO Eliaz Babaev, PhD, was issued a US patent that covers technology employed in the next generation of the company’s Qoustic Wound Therapy System®.

     The Qoustic Wound Therapy System serves as a safe and cost-effective alternative to painful, sharp debridement and other surgical modalities. Light guidance contact produces a dual delivery of low-frequency ultrasound energy directly on the wound bed. This process gently and efficiently debrides the wound and provides stable cavitation to remove dead or diseased tissue, harmful bacteria, and biofilm. Ultrasonic treatment also expedites healing by preserving healthy tissue and protecting granulation tissue, improving circulation through vasodilatation and angiogenesis, and preparing the wound bed for more effective use of downstream therapies such as grafts and flaps.

     Visit http://www.arobella.com for more information.

Oculus Innovative Sciences Launches Microcyn® Wound Care for US Podiatry Market

     Oculus Innovative Sciences Inc (Petaluma, Calif) launched its Microcyn® Wound Care product into the US podiatry market. The product has received 3 FDA 510(k) clearances for use in moistening, lubricating, cleaning, and debriding wounds, and is available to podiatrists for treatment and distribution to patients.

     Oculus began marketing the technology for the US wound care market with an initial focus on podiatry. Based on clinical trial success and positive feedback from a sampling program to US physicians over the past year, Oculus has generated valuable insights as to how medical professionals use the product to treat patients

     Podiatry was one of the areas in which the company witnessed substantial patient benefits and positive physician response. Upon successful completion of the multi-region introduction, the company plans to expand marketing efforts into other US regions—reaching more than 15,000 podiatrists in the United States.

     Visit http://www.oculusis.com for more information.

Glycotex Finalizes Business Agreement with Advanced Medical Solutions

     Glycotex Inc (Rockville, Md) recently finalized an agreement with UK based Advanced Medical Solutions (AMS) to study the use of GLYC-101 with wound dressings manufactured by AMS.

     GLYC-101 is intended to stimulate and modulate the natural cascade of wound healing activities of several cell populations. The product candidate, which is currently under development, is a topical gel that should be applied directly on the wound surface. The strategic priorities for GLYC-101 include healing of burn wounds, surgical wounds, venous ulcers, diabetic ulcers, and wound healing following laser ablation.

     Under the agreement, in the event that this first phase of testing yields favorable results or generates data warranting further research, Glycotex and AMS will have an opportunity to extend their collaboration for the purposes of continued research.

     Visit http://www.admedsol.com or http://www.glycotexinc.com for more information.

KCI Receives FDA Approval for Reconstructive Tissue Matrix

     Kinetic Concepts Inc’s (San Antonio, Tex) LifeCell Tissue Matrix wound care product has received 510(k) approval from the US Food and Drug Administration (FDA).

     LifeCell Tissue Matrix is designed for the management of chronic trauma, surgical, and other acute wounds. The product utilizes Strattice® technology—a sterile, reconstructive tissue matrix that supports tissue regeneration. Strattice technology serves as a scaffold that is revascularized and repopulated with patient cells in order to convert them into a functional, living tissue.

     The technology supports overall healing for a range of wounds that includes pressure ulcers, diabetic ulcers, venous ulcers, chronic vascular ulcers, surgical wounds, and trauma wounds. KCI plans to expand the use the matrix scaffold technology in conjunction with its V.A.C.® Therapy System.

     Visit http://www.kci1.com for more information.

National Alliance of Wound Care Receives Accreditation

     The National Alliance of Wound Care (NAWC, Glendale, Wis), a nonprofit organization dedicated to the advancement and promotion of excellence in wound care through the certification of wound care practitioners in the United States, announced that on September 11, 2008, its wound care certification program was granted a 5-year accreditation by the National Commission for Certifying Agencies (NCCA). This accreditation demonstrates the program’s compliance with the NCCA Standards for the Accreditation of Certification Programs. NCCA is the accrediting body of the National Organization for Competency Assurance (NOCA). The NAWC awards qualified healthcare professionals with the Wound Care Certified (WCC) credential.

     Founded in 2003, the NAWC has awarded credentials to more than 6000 multidisciplinary healthcare professionals (including registered nurses, advanced practice nurses, medical doctors, physical therapists, licensed vocational/practical nurses, doctors of osteopathic medicine, physician assistants, podiatrists, physical therapy assistants, and occupational therapists), thus making the NAWC one of the largest wound care credentialing boards in the United States.

     Visit http://www.nawccb.org for more information.